Jordana Joy, Associate Editor

Mark Bullimore, PhD, MCOptom, FAAO, like other ODs, is anxiously awaiting further clinical trial results.

Rafieetary, OD, FAAO, FORS, Dipl ABO, ABCMO, will be joined by a handful of colleagues to discuss the latest in retina in Boston, Massachusetts, from October 8 to 11.

Commercial product shipments will be initiated for patients in October through LENZ’s ePharmacy partner, and the product is anticipated to be available in commercial locations such as retail pharmacies by the middle of the fourth quarter of this year.

Thomas Albini, MD, shares his insights about common cases and the triaging process for patients with ocular trauma.

Catch up on the top stories in optometry during the week of September 22-September 26.

Mark Bullimore, MCOptom, PhD, FAAO, gave a presentation on myopia management alongside Vishakha Thakrar, OD, FAAO, FSLS, at the conference.

Rahul Tonk, MD, MBA, outlines a session he gave alongside Joseph Allen, OD, FAAO, Dipl ABO, at EyeCon 2025.

The lens works to slow the progression of myopia in children aged 6 to 12 years at the initiation of treatment.

The “chip-on-eye” platform works by mimicking the flow of ocular fluids through the endothelial wall.

Diana Canto-Sims, OD, did the digging on private label eyewear companies so you don't have to.

The Delaying the Onset of Nearsightedness Until Treatment (DONUT) study will be the first of its kind in the US.

Much like the rest of the world, the prevalence of myopia in children in the UK is only growing, having more than doubled in the past 50 years.

Catch up on the top stories in optometry during the week of September 15-September 19.

IPV is defined as physical violence, sexual violence, stalking, or psychological aggression that is committed by a current or former spouse or dating partners.

The loans can be used for practice expansion and renovations, purchases of existing practices, funding for retinal imaging equipment, and more.

The country aims to ensure that more than 95% of patients with diabetes receive timely retinal examinations.

The drops are formulated to target bacteria that cause infections such as bacterial conjunctivitis, otitis externa, and swimmer’s ear.

CLI Visionaries will be discussing these initial findings during Vision Expo West in the “Shifting Focus: How the Next Generation Sees Contact Lens Wear and Eye Care” panel.

The study compared visual, refractive, and patient-reported outcomes following implantation of enVista Envy and the enVista monofocal intraocular lens (IOL) in patients undergoing cataract surgery.

The lens will be available to order on September 17 in the US.

The lesion area growth was reduced by more than 50% in its first human clinical trial of K8.

Catch up on the top stories in optometry during the week of September 8-September 12.

A total of 293 optometrists, practice owners, and managers were involved in the survey.

Researchers will investigate a gene in the eye that is crucial for normal vision, but can cause retinal diseases when mutated that often lead to blindness.

wavelight plus was first launched in China, with several European and Asia-Pacific markets following suit.

Award winners will be recognized during the Academy 2025 meeting in Boston, Massachusetts, running from October 8 to 11.

Xiidra is a prescription eye drop used to treat the signs and symptoms of dry eye disease (DED) and works by targeting the source of inflammation.

The trial will evaluate the solution in treating significant, chronic night driving impairment in keratorefractive patients with reduced mesopic vision.

The lens portfolio includes spherical, aspheric, toric, multifocal, multifocal toric, reverse geometry, and keratoconic contact lenses.

Catch up on the top stories in optometry during the week of September 1-September 5.